26 May 2013
Keywords: fidelity, takes, stake, crucell, dutch, biotechnology, company
Article | 04 July 2005
Dutch biotechnology company Crucell NV has said that Fidelity's FID Growth Company Fund has acquired a 5.13% interest in the share ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 July 2005
24 May 2013
© 2013 thepharmaletter.com